Cargando…

An Overview of Innovative Techniques to Improve Cervical Cancer Screening

Although current cytomorphology-based cervical cancer screening has reduced the incidence of cervical cancer, Papsmears are associated with high false positive and false negative rates. This has spurred the search for new technologies to improve current screening. New methodologies are automation of...

Descripción completa

Detalles Bibliográficos
Autores principales:	Nijhuis, Esther R., Reesink-Peters, Nathalie, Wisman, G. Bea A., Nijman, Hans W., van Zanden, Jelmer, Volders, Haukeline, Hollema, Harry, Suurmeijer, Albert J. H., Schuuring, Ed, van der Zee, Ate G. J.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	IOS Press 2006
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4617820/ https://www.ncbi.nlm.nih.gov/pubmed/17167177 http://dx.doi.org/10.1155/2006/273547

Ejemplares similares

Gene Promoter Methylation Patterns throughout the Process of Cervical Carcinogenesis
por: Yang, Nan, et al.
Publicado: (2010)

Discovery of DNA methylation markers in cervical cancer using relaxation ranking
por: Ongenaert, Maté, et al.
Publicado: (2008)

DNA methylation markers as a triage test for identification of cervical lesions in a high risk human papillomavirus positive screening cohort
por: van Leeuwen, Robert W., et al.
Publicado: (2018)

DNA methylation markers as triage test for the early identification of cervical lesions in a Chinese population
por: Li, Na, et al.
Publicado: (2020)

Genome-wide methylome analysis using MethylCap-seq uncovers 4 hypermethylated markers with high sensitivity for both adeno- and squamous-cell cervical carcinoma
por: Wang, Rong, et al.
Publicado: (2016)

The role of ATM and 53BP1 as predictive markers in cervical cancer
por: Roossink, Frank, et al.
Publicado: (2012)

Markers of fibroblast-rich tumor stroma and perivascular cells in serous ovarian cancer: Inter- and intra-patient heterogeneity and impact on survival
por: Corvigno, Sara, et al.
Publicado: (2016)

Comparing the Cervista HPV HR Test and Hybrid Capture 2 Assay in a Dutch Screening Population: Improved Specificity of the Cervista HPV HR Test by Changing the Cut-Off
por: Boers, Aniek, et al.
Publicado: (2014)

Proteomic alterations in early stage cervical cancer
por: Güzel, Coşkun, et al.
Publicado: (2018)

Methylome analysis of extreme chemoresponsive patients identifies novel markers of platinum sensitivity in high-grade serous ovarian cancer
por: Tomar, Tushar, et al.
Publicado: (2017)

Host-cell DNA methylation patterns during high-risk HPV-induced carcinogenesis reveal a heterogeneous nature of cervical pre-cancer
por: Verlaat, Wina, et al.
Publicado: (2018)

Biobanking of patient and patient-derived xenograft ovarian tumour tissue: efficient preservation with low and high fetal calf serum based methods
por: Alkema, Nicolette G., et al.
Publicado: (2015)

Genome-wide methylation profiling of ovarian cancer patient-derived xenografts treated with the demethylating agent decitabine identifies novel epigenetically regulated genes and pathways
por: Tomar, Tushar, et al.
Publicado: (2016)

CD103+ tumor-infiltrating lymphocytes are tumor-reactive intraepithelial CD8+ T cells associated with prognostic benefit and therapy response in cervical cancer
por: Komdeur, Fenne L., et al.
Publicado: (2017)

Mining for viral fragments in methylation enriched sequencing data
por: Mensaert, Klaas, et al.
Publicado: (2015)

Association of homozygous variants of STING1 with outcome in human cervical cancer
por: Lubbers, Joyce M., et al.
Publicado: (2020)

Potential Target Antigens for a Universal Vaccine in Epithelial Ovarian Cancer
por: Vermeij, Renee, et al.
Publicado: (2010)

Multi‐parametric profiling of renal cell, colorectal, and ovarian cancer identifies tumour‐type‐specific stroma phenotypes and a novel vascular biomarker
por: Corvigno, Sara, et al.
Publicado: (2017)

Discovery of new methylation markers to improve screening for cervical intraepithelial neoplasia grade 2/3
por: Boers, A., et al.
Publicado: (2016)

Preferences and Experiences Regarding the Use of the Self-Sampling Device in hrHPV Screening for Cervical Cancer
por: Dieleman, Marjolein, et al.
Publicado: (2021)

Nationwide prevalence of human papillomavirus infection and viral genotype distribution in 37 cities in China
por: Wang, Rong, et al.
Publicado: (2015)

Nuclear COMMD1 Is Associated with Cisplatin Sensitivity in Ovarian Cancer
por: Fedoseienko, Alina, et al.
Publicado: (2016)

Impact of health-related behavioral factors on participation in a cervical cancer screening program: the lifelines population-based cohort
por: Castañeda, Kelly M., et al.
Publicado: (2023)

Survival-Related Profile, Pathways, and Transcription Factors in Ovarian Cancer
por: Crijns, Anne P. G, et al.
Publicado: (2009)

Correction: Association of Promoter Methylation of VGF and PGP9.5 with Ovarian Cancer Progression
por: Brait, Mariana, et al.
Publicado: (2013)

Correction: Association of Promoter Methylation of VGF and PGP9.5 with Ovarian Cancer Progression
por: Brait, Mariana, et al.
Publicado: (2013)

Remaining Need for In Vitro Test to Elucidate 5-Hydroxytryptamine 2C Receptor Functioning
por: Ivanova, Svetlana A., et al.
Publicado: (2018)

The effect of extended participation windows on attendance at cervical cancer screening
por: Castañeda, Kelly M., et al.
Publicado: (2023)

Association of Promoter Methylation of VGF and PGP9.5 with Ovarian Cancer Progression
por: Brait, Mariana, et al.
Publicado: (2013)

ARID1A mutation sensitizes most ovarian clear cell carcinomas to BET inhibitors
por: Berns, Katrien, et al.
Publicado: (2018)

CD103+ intraepithelial T cells in high-grade serous ovarian cancer are phenotypically diverse TCRαβ+ CD8αβ+ T cells that can be targeted for cancer immunotherapy
por: Komdeur, Fenne L., et al.
Publicado: (2016)

The potential of combined mutation sequencing of plasma circulating cell‐free DNA and matched white blood cells for treatment response prediction
por: van der Leest, Paul, et al.
Publicado: (2020)

Kinome capture sequencing of high-grade serous ovarian carcinoma reveals novel mutations in the JAK3 gene
por: Mittempergher, Lorenza, et al.
Publicado: (2020)

Combined STING levels and CD103+ T cell infiltration have significant prognostic implications for patients with cervical cancer
por: Kol, Arjan, et al.
Publicado: (2021)

Glutathione S-transferase activity and isoenzyme composition in benign ovarian tumours, untreated malignant ovarian tumours, and malignant ovarian tumours after platinum/cyclophosphamide chemotherapy.
por: van der Zee, A. G., et al.
Publicado: (1992)

Tyrosine kinase inhibitor sensitive PDGFRΑ mutations in GIST: Two cases and review of the literature
por: Boonstra, Pieter A., et al.
Publicado: (2017)

History and Updates of the GROINSS-V Studies
por: Wagner, Marise M., et al.
Publicado: (2022)

First-in-Human Phase I Clinical Trial of an SFV-Based RNA Replicon Cancer Vaccine against HPV-Induced Cancers
por: Komdeur, Fenne L., et al.
Publicado: (2021)

The ErbB signalling pathway: protein expression and prognostic value in epithelial ovarian cancer
por: de Graeff, P, et al.
Publicado: (2008)

Comparative genome analysis of cortactin and HS1: the significance of the F-actin binding repeat domain
por: van Rossum, Agnes GSH, et al.
Publicado: (2005)

Cannot write session to /tmp/vufind_sessions/sess_3s74ink72doitnktdtbs4jl50g